A Study of a Cohort of X-Linked Myotubular Myopathy at the Clinical, Histologic, and Genetic Levels

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2016
Editora
ELSEVIER SCIENCE INC
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
SILVA, Marina Rodrigues e
OLIVEIRA, Acary de Souza Bulle
BIANCALANA, Valerie
PESQUERO, Joao Bosco
LAPORTE, Jocelyn
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PEDIATRIC NEUROLOGY, v.58, p.107-112, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Myotubular myopathy is a rare X-linked congenital myopathy characterized by marked neonatal hypotonia and respiratory insufficiency, facial and ocular involvement, and muscle biopsy with prominent central nuclei in the majority of muscle fibers. It is caused by mutations in MTM1, which codes for the phosphoinositides phosphatase myotubularin. In this work, we established and detailed a new cohort of six patients at the clinical, histologic, and genetic levels. PATIENTS AND METHODS: Patients were recruited after screening 3065 muscle biopsy reports from two large biopsy banks in Sao Paulo, Brazil from the years 2008 to 2013, and from referrals to a neuromuscular outpatient clinic between 2011 and 2013. We reviewed biopsy slides, evaluated patients, and Sanger sequenced MTM1 in the families. RESULTS: All patients but one had classic phenotypes with a stable course after a severe onset. Two patients died suddenly from hypovolemic shock. Muscle biopsies had been performed in five patients, all of whom showed a classic pattern with a predominance of centrally located nuclei and increased oxidative activity in the center of the fibers. Two patients showed necklace fibers, and two families had novel truncating mutations in MTM1. CONCLUSIONS: X-linked myotubular myopathy is rare in the Brazilian population. Necklace fibers might be more prevalent in this condition than previously reported. Direct Sanger sequencing of MTM1 on clinical suspicion avoids the need of a muscle biopsy.
Palavras-chave
centronuclear myopathy, myotubular myopathy, MTM1, myotubularin, congenital myopathy
Referências
  1. Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510
  2. Bevilacqua JA, 2009, ACTA NEUROPATHOL, V117, P283, DOI 10.1007/s00401-008-0472-1
  3. Biancalana V, 2003, HUM GENET, V112, P135, DOI 10.1007/s00439-002-0869-1
  4. deGouyon BM, 1997, HUM MOL GENET, V6, P1499, DOI 10.1093/hmg/6.9.1499
  5. den Dunnen JT, 2000, HUM MUTAT, V15, P7
  6. Gurgel-Giannetti J, 2012, NEUROMUSCULAR DISORD, V22, P541, DOI 10.1016/j.nmd.2011.12.005
  7. Hagiwara SI, 2015, J PEDIAT GASTROENTER, V60, P45
  8. Herman GE, 1999, J PEDIATR-US, V134, P206, DOI 10.1016/S0022-3476(99)70417-8
  9. Herman GE, 2002, HUM MUTAT, V19, P114, DOI 10.1002/humu.10033
  10. Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26
  11. Karger B, 2005, INT J LEGAL MED, V119, P44, DOI 10.1007/s00414-004-0482-z
  12. Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175
  13. Laporte J, 1997, HUM MOL GENET, V6, P1505, DOI 10.1093/hmg/6.9.1505
  14. Laporte J, 2000, HUM MUTAT, V15, P393, DOI 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R
  15. Lawlor MW, 2014, AM J PATHOL, V184, P1831, DOI 10.1016/j.ajpath.2014.03.003
  16. Maggi L, 2013, NEUROMUSCULAR DISORD, V23, P195, DOI 10.1016/j.nmd.2013.01.004
  17. McEntagart M, 2002, NEUROMUSCULAR DISORD, V12, P939, DOI 10.1016/S0960-8966(02)00153-0
  18. MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
  19. Motoki T, 2013, NEUROMUSCULAR DISORD, V23, P917, DOI 10.1016/j.nmd.2013.06.008
  20. Oliveira J, 2013, EUR J HUM GENET, V21, P540, DOI 10.1038/ejhg.2012.201
  21. Pierson CR, 2012, HUM MOL GENET, V21, P811, DOI 10.1093/hmg/ddr512
  22. Pierson CR, 2007, NEUROMUSCULAR DISORD, V17, P562, DOI 10.1016/j.nmd.2007.03.010
  23. Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014
  24. Sher JH, 1967, NEUROLOGY, V17
  25. SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1
  26. Tanner SM, 1999, NEUROMUSCULAR DISORD, V9, P41, DOI 10.1016/S0960-8966(98)00090-X
  27. Wang SY, 2001, J PEDIATR SURG, V36, P1456, DOI 10.1053/jpsu.2001.26397
  28. Yu S, 2003, CLIN GENET, V64, P148, DOI 10.1034/j.1399-0004.2003.00118.x
  29. Zanoteli E, 2005, AM J MED GENET A, V134A, P338, DOI 10.1002/ajmg.a.30574